SCHEMBL7141773

SCHEMBL7141773

COCCOCCOCCOCCOc1cc(NC(=O)OC(C)(C)C)c([N+](=O)[O-])cc1I

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.42
KDM4E B2RXH2 3/20 0.42
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 3/20 0.39
MAPK1 P28482 2/20 0.39
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
BCHE P06276 1/20 0.37
CNR2 P34972 1/20 0.37
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141800 0.97 NPC1 (0.41) ALDH1A1KDM4ECYP1A2CYP2C9NPC1
SCHEMBL7147448 0.89 NPC1 (0.39) ALDH1A1KDM4ECYP1A2CYP2C9NPC1
SCHEMBL7141612 0.84 PKM (0.43) ALDH1A1MAPTSMN1; SMN2KMT2AMEN1
SCHEMBL7144299 0.83 TDP1 (0.40) ALDH1A1CYP1A2CYP2C9NPC1RAB9A
SCHEMBL7698485 0.83 MEN1 (0.40) ALDH1A1CYP1A2CYP2C9NPC1RAB9A
SCHEMBL5563828 0.82 HTT (0.40) ALDH1A1KDM4ECYP1A2MAPTLMNA
SCHEMBL6166451 0.82 CYP1A2 (0.37) ALDH1A1CYP1A2CYP2C9NPC1RAB9A
SCHEMBL7145419 0.81 MMP1 (0.39) ALDH1A1CYP1A2NPC1RAB9AMAPT
SCHEMBL7147417 0.81 NPC1 (0.36) ALDH1A1CYP1A2CYP2C9NPC1RAB9A
SCHEMBL7141508 0.81 ALDH1A1 (0.36) ALDH1A1KDM4ECYP1A2CYP2C9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed